leadf
logo-loader
viewProtea Biosciences Group Inc

Protea reveals Protein Metrics partnership

“Biopharma is in need of these new bioanalytical capabilities,” Protea’s Kilby said.

shutterstock_327930536_56c4923fc2bef.jpg
“Biopharma is in need of these new bioanalytical capabilities,” Protea’s Kilby said.

Protea Biosciences Group (OTCQB:PRGB) announced it is teaming up with software provider Protein Metrics to advance the development of protein biotherapeutics.

Greg Kilby, Protea’s vice president and chief operating officer, said: “We are positioning Protea to be a leader in the next generation of bioanalytics, focused on the needs of the biotherapeutics industry.”

The collaboration will provide Protea access to advanced analytics software, allowing the two to combine technologies.

“Biopharma is in need of these new bioanalytical capabilities,” Protea’s Kilby said.

Chris Becker, chief executive of Protein Metrics, said: “We are delighted to partner with Protea Biosciences and are looking forward to seeing our software advance the results they provide their clients.”

Quick facts: Protea Biosciences Group Inc

Price: - -

GREY:PRGBQ
Market: GREY
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Lexaria Bioscience proves technology works in enhancing oral delivery of...

Lexaria Bioscience (OTCQX:LXRP-CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive with news the company has announced that its DehydraTECH technology significantly improved delivery in study animals of representative drugs from two classes of antiviral therapies. Bunka telling...

1 hour, 9 minutes ago

2 min read